Management of Psoriasis in children by Sivanarvembu Kuzhi Thailam with Sivanarvembu Chooranam as Internal and Narseeraga Thailam as External

Single centric, Non-Randomized, An open clinical trial to evaluate the effectiveness of Sivanarvembu Kuzhi Thailam with Sivanarvembu Chooranam as Internal and Narseeraga Thailam as External in the management of Kalanjagapadai (Psoriasis) in children. - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058492

Enrollment

Registered

2023-10-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L80-L99- Other disorders of the skin and subcutaneous tissue

Interventions

Intervention1: SIVANARVEMBU KUZHI THAILAM WITH SIVANRVEMBU CHOORANAM (INTERNAL) AND NARSEERAGA THAILAM (EXTERNAL): INTERNAL MEDICINE: 1.SIVANARVEMBU KUZHI THAILAM: Dosage: Kaasedai (400 mg), BD After

Eligibility

Inclusion criteria

Inclusion criteria: 1.Age: 5 – 12 years 2.Sex: Both male and female children. 3.Patients with two or more of the following symptoms • Erythema • Scaling • Dryness of the skin • Thickness of the skin with or without itching • Cracks followed by itching • Candle grease sign +ve • Auspitz sign +ve 4.Willing to cooperate for taking photographs whenever required with consent. 5.Patients who are willing to stay in IPD Ward or willing to attend OP Dept. as on required. 6.Parent / Patient’s informant willing to sign in the informed consent.

Exclusion criteria

Exclusion criteria: ? Psoriatic arthritis ? Psoriasis with evidence of any other skin diseases 1.Psoratic lesions with secondary infection 2.K/H/O Eczema 3.K/H/O Fungal infection 4.K/H/O Epilepsy 5.Any another Systemic (Cardiac) involvement

Design outcomes

Primary

Measure	Time frame
To evaluate the effectiveness of Sivanarvembu Kuzhi Thailam with Sivanarvembu Chooranam as Internal and Narseeraga Thailam as external for the management of Kalanjagapadai (Psoriasis) in Children.Timepoint: Weekly once	—

Secondary

Measure	Time frame
1.To study the occurrence of new lesions anywhere else in the body after intake of trial medicine. 2.To improve the quality of life in Children. Timepoint: 7 days once	—

Countries

India

Contacts

Public ContactDr Megganah

National Institute Of Siddha

gvennils@gmail.com9789093986

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026